Insulet FY 2022: revenue $1.3B, up 19%; diluted EPS $0.07

Key figures from this report

These are the numbers Insulet reported for the year ended Dec 31, 2022, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

1. Revenue$1.3B+19% from $1.1B in FY 202110-K income statement, on EDGAR
2. Net income$4.6M−73% from $16.8M in FY 202110-K income statement, on EDGAR
3. Diluted EPS$0.07−71% from $0.24 in FY 202110-K income statement, on EDGAR
4. Cash and cash equivalents$689.7M−14% from $806.4M in FY 202110-K balance sheet, on EDGAR
5. Cash from operations$119.0MAgainst −$68.1M in FY 202110-K cash flow statement, on EDGAR

Every year in the financial tables